A carregar...
A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
Temozolomide (TMZ) is the first-line chemotherapy drug that has been used to treat glioma for over a decade, but the benefits are limited by half of the treated patients who acquired resistance. Studies have shown that glioma TMZ resistance is a complex process with multiple factors, which has not b...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020-06-01
|
| Colecção: | Frontiers in Oncology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/article/10.3389/fonc.2020.00897/full |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|